These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27484624)

  • 21. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
    Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z
    Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation.
    Patel K; Trivedi RN; Durgampudi C; Noel P; Cline RA; DeLany JP; Navina S; Singh VP
    Am J Pathol; 2015 Mar; 185(3):808-19. PubMed ID: 25579844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis.
    Point V; Bénarouche A; Zarrillo J; Guy A; Magnez R; Fonseca L; Raux B; Leclaire J; Buono G; Fotiadu F; Durand T; Carrière F; Vaysse C; Couëdelo L; Cavalier JF
    Eur J Med Chem; 2016 Nov; 123():834-848. PubMed ID: 27543878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and kinetic evaluation of cyclophostin and cyclipostins phosphonate analogs as selective and potent inhibitors of microbial lipases.
    Point V; Malla RK; Diomande S; Martin BP; Delorme V; Carriere F; Canaan S; Rath NP; Spilling CD; Cavalier JF
    J Med Chem; 2012 Nov; 55(22):10204-19. PubMed ID: 23095026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.
    Borgström B
    Biochim Biophys Acta; 1988 Oct; 962(3):308-16. PubMed ID: 3167082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural inhibitors of pancreatic lipase as new players in obesity treatment.
    de la Garza AL; Milagro FI; Boque N; Campión J; Martínez JA
    Planta Med; 2011 May; 77(8):773-85. PubMed ID: 21412692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
    Hill JO; Hauptman J; Anderson JW; Fujioka K; O'Neil PM; Smith DK; Zavoral JH; Aronne LJ
    Am J Clin Nutr; 1999 Jun; 69(6):1108-16. PubMed ID: 10357727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for obesity.
    Williamson DF
    JAMA; 1999 Jan; 281(3):278-80. PubMed ID: 9918485
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of lipases from Chromobacterium viscosum and Rhizopus oryzae by tetrahydrolipstatin.
    Potthoff AP; Haalck L; Spener F
    Biochim Biophys Acta; 1998 Jan; 1389(2):123-31. PubMed ID: 9461253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orlistat inhibits dietary cholesterol absorption.
    Mittendorfer B; Ostlund RE; Patterson BW; Klein S
    Obes Res; 2001 Oct; 9(10):599-604. PubMed ID: 11595776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescent organophosphonates as inhibitors of microbial lipases.
    Oskolkova OV; Saf R; Zenzmaier E; Hermetter A
    Chem Phys Lipids; 2003 Oct; 125(2):103-14. PubMed ID: 14499469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin.
    Hadváry P; Lengsfeld H; Wolfer H
    Biochem J; 1988 Dec; 256(2):357-61. PubMed ID: 3223916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological parameters governing the action of pancreatic lipase.
    Brownlee IA; Forster DJ; Wilcox MD; Dettmar PW; Seal CJ; Pearson JP
    Nutr Res Rev; 2010 Jun; 23(1):146-54. PubMed ID: 20193096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.
    Langin D
    Pharmacol Res; 2006 Jun; 53(6):482-91. PubMed ID: 16644234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of surfactants on lipase structure, activity, and inhibition.
    Delorme V; Dhouib R; Canaan S; Fotiadu F; Carrière F; Cavalier JF
    Pharm Res; 2011 Aug; 28(8):1831-42. PubMed ID: 21234659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase.
    Hadváry P; Sidler W; Meister W; Vetter W; Wolfer H
    J Biol Chem; 1991 Feb; 266(4):2021-7. PubMed ID: 1899234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones.
    Point V; Pavan Kumar KV; Marc S; Delorme V; Parsiegla G; Amara S; Carrière F; Buono G; Fotiadu F; Canaan S; Leclaire J; Cavalier JF
    Eur J Med Chem; 2012 Dec; 58():452-63. PubMed ID: 23153815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of lipolysis in oral cavity for orosensory detection of fat.
    Kawai T; Fushiki T
    Am J Physiol Regul Integr Comp Physiol; 2003 Aug; 285(2):R447-54. PubMed ID: 12702486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influences of fat restriction and lipase inhibition on gastric emptying in obesity.
    Mathus-Vliegen EM; van Ierland-van Leeuwen ML; Bennink RJ
    Int J Obes (Lond); 2006 Aug; 30(8):1203-10. PubMed ID: 16462818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.